0000000000018487

AUTHOR

Isidro Machado

showing 55 related works from this author

Controversial issues in soft tissue solitary fibrous tumors: A pathological and molecular review

2019

The clinical evolution of solitary fibrous tumor (SFT) remains unclear. Although various clinical, morphological and molecular criteria may indicate increased risk of malignancy, some SFT can still progress despite having a clearly benign appearance. Various risk stratification systems have been proposed, but unfortunately they are not sufficient to precisely determine the malignant potential. In this review, we discuss current knowledge on SFT, focusing on the following controversial issues: (i) the diverse morphologic spectrum: 'the great simulator;' (ii) malignant transformation or dedifferentiation; (iii) current risk stratification systems; and (iv) molecular factors associated with cl…

Risk0301 basic medicinePathologymedicine.medical_specialtySolitary fibrous tumorMalignancyPathology and Forensic MedicineMalignant transformationDiagnosis Differential03 medical and health sciences0302 clinical medicinemedicineHumansPathologicalbusiness.industrySoft tissueGeneral MedicineCell DedifferentiationPrognosismedicine.diseaseImmunohistochemistryCell Transformation Neoplastic030104 developmental biologyIncreased riskSolitary Fibrous Tumors030220 oncology & carcinogenesisRisk stratificationbusinessPathology International
researchProduct

Angiosarcomas y síndrome de Kasabach-Merritt, una asociación con evolución clínica agresiva. A propósito de 2 casos con estudio necrópsico

2015

Resumen Los angiosarcomas son neoplasias malignas agresivas con diferenciacion de celulas endoteliales. La hemorragia espontanea debida a una coagulacion intravascular diseminada con coagulopatia de consumo es una forma poco comun de presentacion de estos tumores denominada sindrome de Kasabach-Merritt. En el presente estudio describimos 2 casos con estudio necropsico de angiosarcomas complicado con sindrome de Kasabach-Merritt. El primer caso con diagnostico de angiosarcoma mediastinico asociado a un tumor de celulas germinales y el segundo caso con angiosarcoma primario hepatico y multiples metastasis.

Pathology and Forensic MedicineRevista Española de Patología
researchProduct

The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation.

2014

The Ewing sarcoma family of tumors (EFT) is a group of highly malignant small round blue cell tumors occurring in children and young adults. We report here the largest genomic survey to date of 101 EFT (65 tumors and 36 cell lines). Using a combination of whole genome sequencing and targeted sequencing approaches, we discover that EFT has a very low mutational burden (0.15 mutations/Mb) but frequent deleterious mutations in the cohesin complex subunit STAG2 (21.5% tumors, 44.4% cell lines), homozygous deletion of CDKN2A (13.8% and 50%) and mutations of TP53 (6.2% and 71.9%). We additionally note an increased prevalence of the BRCA2 K3326X polymorphism in EFT patient samples (7.3%) compared …

MaleCancer ResearchCell Cycle Proteinsmedicine.disease_causeFusion geneCDKN2AMedicine and Health Sciences2.1 Biological and endogenous factorsAetiologyChildGenetics (clinical)CancerPediatricMutationTissue microarrayTumorGenomeSarcomasHigh-Throughput Nucleotide SequencingAntigens NuclearSarcomaNeoplasm ProteinsOncologyChild PreschoolFemaleSarcomaResearch ArticleBiotechnologyHumanAdultPediatric Research Initiativelcsh:QH426-470Cohesin complexAdolescentPediatric CancerEwing SarcomaSarcoma EwingBiologyDisease-Free SurvivalFrameshift mutationCell LineGermline mutationRare DiseasesCell Line TumorEwingCancer GeneticsmedicineGeneticsHumansNuclearGenetic TestingAntigensPreschoolMolecular BiologyEcology Evolution Behavior and SystematicsGenome HumanHuman GenomeBiology and Life SciencesCancers and NeoplasmsInfantmedicine.diseaselcsh:GeneticsOrphan DrugMutationCancer researchGene DeletionDevelopmental Biology
researchProduct

Biomarkers in the Ewing sarcoma family of tumors

2014

business.industryBiochemistry (medical)Clinical BiochemistryCancer researchMedicineSarcomabusinessmedicine.diseaseBiochemistryCurrent Biomarker Findings
researchProduct

miR‐200c and phospho‐AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis

2016

Lung metastasis is the major cause of death in osteosarcoma patients. However, molecular mechanisms underlying this metastasis remain poorly understood. To identify key molecules related with pulmonary metastasis of pediatric osteosarcomas, we analyzed high-throughput miRNA expression in a cohort of 11 primary tumors and 15 lung metastases. Results were further validated with an independent cohort of 10 primary tumors and 6 metastases. In parallel, we performed immunohistochemical analysis of activated signaling pathways in 36 primary osteosarcomas. Only phospho-AKT associated with lower overall survival in primary tumors, supporting its role in osteosarcoma progression. CTNNB1 expression a…

0301 basic medicineOncologyMaleCancer ResearchmiR‐200cLung NeoplasmsCDH1MetastasisCohort Studies0302 clinical medicineCell MovementPhospho‐AKTPhosphorylationChildOsteosarcomabiologyGeneral MedicineArticlesCadherinsPrognosisPrimary tumorGene Expression Regulation Neoplasticmedicine.anatomical_structureLung metastasisOncology030220 oncology & carcinogenesisDisease ProgressionMolecular MedicineOsteosarcomaFemaleSignal Transductionmedicine.medical_specialtyAdolescentMesenchymal to epithelial transitionArticle03 medical and health sciencesYoung AdultAntigens CDInternal medicineCell Line TumormicroRNAGeneticsmedicineBiomarkers TumorHumansEpithelial–mesenchymal transitionCell ProliferationLungGene Expression ProfilingReproducibility of ResultsEpithelial CellsPediatric osteosarcomamedicine.diseaseSurvival AnalysisEnzyme ActivationMicroRNAs030104 developmental biologyTumor progressionbiology.proteinProto-Oncogene Proteins c-aktMolecular Oncology
researchProduct

Tissue microarrays: applications in study of p16 and p53 alterations in Ewing's cell lines

2008

Background Tissue microarrays (TMAs) are used to study genomics and proteomics in several tumour tissue samples. Cell lines (CC) are of great importance in the study of the genetic changes in tumours, and some reveal several aspects of tumour oncogenesis. There are few published reports on Ewing's tumours with TMAs including original tumours (OT) and corresponding CC. Methods We have performed four TMAs, from 3 OT and the corresponding CC of successive in vivo and in vitro tumour passages. Xenotransplant CC in nude mice from OT (XT/OT) was made. Subsequently multiple XT were performed and in vitro XT cell line (CC/XT) was obtained. In vivo re-inoculation of CC/XT (XT/CC) was planned. TMAs w…

MonosomyPathologymedicine.medical_specialtyTissue microarrayHistologyCD99General MedicineBiologymedicine.diseasemedicine.disease_causePathology and Forensic MedicineChromosome 17 (human)Fusion geneProceedingsIn vivomedicineImmunohistochemistryCarcinogenesisDiagnostic Pathology
researchProduct

Malignant PEComa With Metastatic Disease at Diagnosis and Resistance to Several Chemotherapy Regimens and Targeted Therapy (m-TOR Inhibitor).

2017

Perivascular epithelioid cell tumors (PEComas) are infrequent neoplasms with peculiar myomelanocytic differentiation. The aggressive abdominopelvic variant is rare, with only a small number of published cases. We present an additional case of this unusual variant, which showed an aggressive histologic and clinical behavior with multiple liver metastases and resistance to several therapies. We also discuss the histological and immunohistochemical profiles as well as the differential diagnosis.

0301 basic medicineAdultPathologymedicine.medical_specialtyPerivascular Epithelioid Cell Neoplasmsmedicine.medical_treatmentAntineoplastic AgentsDiseasePathology and Forensic MedicineTargeted therapy03 medical and health sciences0302 clinical medicineMedicineHumansMolecular Targeted TherapyChemotherapybusiness.industryTOR Serine-Threonine Kinasesmedicine.diseasePerivascular Epithelioid Cell Tumors030104 developmental biologyDrug Resistance Neoplasm030220 oncology & carcinogenesisImmunohistochemistrySurgeryFemaleSarcomaAnatomyDifferential diagnosisbusinessInternational journal of surgical pathology
researchProduct

Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations

2011

BACKGROUND: Human tumors transplanted into immunodeficient mice (xenografts) are good preclinical models, and it is important to identify possible systematic changes during establishment and passaging in mice. METHODS: High-resolution microarray-based comparative genomic hybridization (array CGH) was used to investigate how well a series of sarcoma xenografts, including 9 patient/xenograft pairs and 8 early versus late xenograft passage pairs, represented the patient tumor from which they originated. RESULTS: In all analyses, the xenografts were more similar to their tumor of origin than other xenografts of the same type. Most changes in aberration patterns were toward a more normal genome …

Cancer ResearchPathologymedicine.medical_specialtyMicroarraybiologyCancerPDGFRAbiology.organism_classificationmedicine.diseaseTransplantationNude mouseOncologyTumor progressionmedicineSarcomaComparative genomic hybridizationCancer
researchProduct

Lung Metastases from Esophageal Granular Cell Tumor: An Undoubted Criterion for Malignancy

2017

0301 basic medicinePulmonary and Respiratory MedicineOncologymedicine.medical_specialtyPathologyLung NeoplasmsEsophageal NeoplasmsMalignancy03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansNeoplasm MetastasisGranular cell tumorLungbusiness.industryMiddle Agedmedicine.disease030104 developmental biologymedicine.anatomical_structureOncologyGranular Cell Tumor030220 oncology & carcinogenesisEsophageal Granular Cell TumorFemalebusinessJournal of Thoracic Oncology
researchProduct

Chemokine Expression Is Involved in the Vascular Neogenesis of Ewing Sarcoma: A Preliminary Analysis of the Early Stages of Angiogenesis in a Xenogra…

2018

Background Ewing sarcoma (EWS) is the second most common bone cancer in pediatric patients. Angiogenesis is a major factor for tumor growth and metastasis. Our aim was to carry out a histological, immunohistochemical, and molecular characterization of the neovascularization established between xenotransplanted tumors and the host during the initial phases of growth in nude mice in three angiogenesis experiments (ES2, ES3, and ES4). Methods The original human EWS were implanted subcutaneously on the backs of three nude mice. Tumor pieces 3 mm–4 mm in size from early passages of Nu432, Nu495, and Nu471 were also implanted subcutaneously on the backs of three sets (ES2, ES3, and ES4) of athymi…

ChemokineAngiogenesisMice NudeBone NeoplasmsSarcoma EwingNeogenesisPathology and Forensic MedicinePreliminary analysisMetastasis03 medical and health sciencesMice0302 clinical medicinemedicineBiomarkers TumorAnimalsHumansTumor growthMice Inbred BALB C030219 obstetrics & reproductive medicinebiologyNeovascularization Pathologicbusiness.industryBone cancerGeneral Medicinemedicine.diseasebiology.organism_classificationImmunohistochemistryMicroscopy Electron030220 oncology & carcinogenesisPediatrics Perinatology and Child HealthCancer researchbiology.proteinSarcomaChemokinesbusinessNeoplasm TransplantationPediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
researchProduct

Gain of MYCN region in a Wilms tumor-derived xenotransplanted cell line.

2010

Wilms tumor is one of the most common pediatric malignant tumors of the kidney. Although the WT1 gene, located at 11p13, has been proven to be implicated in the development of Wilms tumor, other genes such as MYCN are also involved. The purpose of this study is to genetically characterize a Wilms tumor metastasis xenotransplanted in nude mice. Immunogenotype evolution of the xenografts material was monitored for 29 months using molecular techniques, fluorescent in situ hybridization and multiplex ligation-dependent probe amplification, in addition to immunohistochemistry in tissue microarrays. Genetic alterations present in the original tumor and retained in the xenotransplanted tumor were …

MaleTransplantation HeterologousMice NudeIn situ hybridizationBiologyN-Myc Proto-Oncogene ProteinWilms TumorPathology and Forensic MedicineMetastasisExonMiceINDEL MutationmedicineAnimalsHumansneoplasmsMolecular BiologyIn Situ Hybridization FluorescenceOncogene ProteinsN-Myc Proto-Oncogene ProteinTissue microarrayNuclear ProteinsWilms' tumorCell BiologyNucleic acid amplification techniquemedicine.diseaseMolecular biologyImmunohistochemistryTransplantationChild PreschoolNucleic Acid Amplification TechniquesDiagnostic molecular pathology : the American journal of surgical pathology, part B
researchProduct

The Epithelial Mesenchymal Transition Process in Wilms Tumor

2011

Background Until now, only a few mouse-transplanted human tumors or experimental Wilms tumor (WT) cell lines have been described. The aim of this study was to show the biological behavior, including histology, immunohistochemistry (IHC), and molecular biology, of a WT including the original tumor and metastasis transferred into nude mice and followed for successive generations in xenografts. Methods A WT metastasis was xenotransplanted into nude mice and the mice was monitored for 7 passages over a period of 29 months; the original neoplasm was comparatively studied. The morphology was evaluated by optical and electron microscopy. The protein expression was analyzed by immunohistochemistry …

Epithelial-Mesenchymal TransitionHistologyDNA Mutational AnalysisMice NudeCell Growth ProcessesWilms TumorBone and BonesPathology and Forensic MedicineMetastasisMicemedicineAnimalsHumansEpithelial–mesenchymal transitionNeoplasm MetastasisOncogene ProteinsN-Myc Proto-Oncogene ProteinTissue microarrayChemistryMesenchymal stem cellNuclear ProteinsEye Diseases HereditaryWilms' tumorHistologyStriated muscle cell differentiationMicroarray Analysismedicine.diseaseImmunohistochemistryXenograft Model Antitumor AssaysKidney NeoplasmsWnt ProteinsRadiusMedical Laboratory TechnologyMutationCancer researchImmunohistochemistrySignal TransductionApplied Immunohistochemistry & Molecular Morphology
researchProduct

(Immuno)histological Analysis of Ewing Sarcoma

2020

The diagnosis of Ewing sarcoma requires the integration of the information generated from numerous techniques, some of them being very sophisticated. However, the first steps of the diagnostic process are crucial to achieve the maximum possible diagnostic performance. In this chapter we will review how to handle the diagnostic specimen from its collection, how to prepare it for diagnosis, how to make a complete pathology report, and provide guidance for the reasonable use of immunohistochemical techniques in this malignancy.

0301 basic medicinePathologymedicine.medical_specialtyBone decalcificationbusiness.industrymedicine.medical_treatmentPathology Reportmedicine.diseaseMalignancy03 medical and health sciences030104 developmental biology0302 clinical medicine030220 oncology & carcinogenesismedicineImmunohistochemistrySarcomaDifferential diagnosisbusinessNeoadjuvant therapy
researchProduct

Quantification of the heterogeneity of prognostic cellular biomarkers in ewing sarcoma using automated image and random survival forest analysis

2014

Driven by genomic somatic variation, tumour tissues are typically heterogeneous, yet unbiased quantitative methods are rarely used to analyse heterogeneity at the protein level. Motivated by this problem, we developed automated image segmentation of images of multiple biomarkers in Ewing sarcoma to generate distributions of biomarkers between and within tumour cells. We further integrate high dimensional data with patient clinical outcomes utilising random survival forest (RSF) machine learning. Using material from cohorts of genetically diagnosed Ewing sarcoma with EWSR1 chromosomal translocations, confocal images of tissue microarrays were segmented with level sets and watershed algorithm…

PathologyCytoplasmMicroarrayslcsh:MedicineCohort StudiesMedicine and Health Scienceslcsh:ScienceMultidisciplinaryTissue microarrayApplied MathematicsPrognosisRandom forestBioassays and Physiological AnalysisOncologyFeature (computer vision)Research DesignPhysical SciencesBiomarker (medicine)SarcomaAnatomyAlgorithmsStatistics (Mathematics)Research Articlemedicine.medical_specialtyComputer and Information SciencesHistologyClinical Research DesignCD99Feature selectionBone NeoplasmsComputational biologySarcoma EwingBiology12E7 AntigenResearch and Analysis MethodsAntigens CDArtificial IntelligenceCell Line TumormedicineCancer Detection and DiagnosisBiomarkers TumorHumansStatistical MethodsCell Nucleuslcsh:RBiology and Life SciencesComputational BiologyImage segmentationmedicine.diseaselcsh:QCell Adhesion MoleculesMathematicsPLoS ONE
researchProduct

Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone

2012

Abstract Background Chondrosarcoma is the second most common primary sarcoma of bone. High-grade conventional chondrosarcoma and dedifferentiated chondrosarcoma have a poor outcome. In pre-clinical research aiming at the identification of novel treatment targets, the need for representative cell lines and model systems is high, but availability is scarce. Methods We developed and characterized three cell lines, derived from conventional grade III chondrosarcoma (L835), and dedifferentiated chondrosarcoma (L2975 and L3252) of bone. Proliferation and migration were studied and we used COBRA-FISH and array-CGH for karyotyping and genotyping. Immunohistochemistry for p16 and p53 was performed a…

MaleBone neoplasmCancer ResearchPathologymedicine.medical_specialtyIDH1Transplantation HeterologousChondrosarcomaMice NudeBone Neoplasmsp16Bone neoplasmlcsh:RC254-282MiceTreatment targetsCell MovementCell Line TumorGeneticsmedicineAnimalsHumansDedifferentiated chondrosarcomaIn Situ Hybridization FluorescenceComparative Genomic HybridizationNeoplasm Gradingbusiness.industryConventional ChondrosarcomaMiddle Agedlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseRadiographyRadiusOncologyMutationIDH1IDH2Neoplasm GradingChondrosarcomaCell linebusinessPrimary sarcomaResearch ArticleBMC Cancer
researchProduct

Ewing’s Sarcoma Family of Tumors

2020

Ewing’s sarcoma family of tumors (ESFT) is a family of small round cell sarcomas with specific molecular alterations showing a spectrum of neuroectodermal differentiation. There is a slightly greater incidence in males than females. The first two decades of life account for 80 % of patients (age at diagnosis ranges from 13 to 19 years), being more uncommon in adults and elderly patients and more frequent in white (Caucasian) people.

Pathologymedicine.medical_specialtyNeuroectodermal Differentiationbusiness.industryIncidence (epidemiology)Metastatic neuroblastomamedicineRound cellEwing's sarcomaAge at diagnosisSarcomamedicine.diseasebusiness
researchProduct

Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's sarcoma family of tumors.

2010

More than 90% of all Ewing's Sarcoma Family of Tumors (ESFT) exhibit specific chromosomal rearrangements between the EWS gene on chromosome 22 and various members of the ETS gene family of transcription factors. The gene fusion type and other secondary genetic alterations, mainly involving cell cycle regulators, have been shown to be of prognostic relevance in ESFT. However, no conclusive results have been reported. We analyzed the clinicopathological significance of relevant cell cycle regulators in genetically confirmed ESFT. A total of 324 cases were analyzed for the immunohistochemical expression of p53, p21(Waf1/Cip1) , p27(Kip1) and Ki67 and the chromosomal alterations of the p53 and …

AdultMaleCancer ResearchPathologymedicine.medical_specialtyAdolescentChromosomes Human Pair 22Sarcoma EwingBiologyFusion geneCohort StudiesYoung AdultGene mappingmedicineBiomarkers TumorHumansProgression-free survivalChildIn Situ Hybridization FluorescenceAgedAged 80 and overCell CycleCancerEwing's sarcomaInfantCell cycleMiddle Agedmedicine.diseaseGenes p53ImmunohistochemistryOncologyChild PreschoolCancer researchFemaleSarcomaChromosome DeletionRNA-Binding Protein EWSChromosome 22International journal of cancer
researchProduct

Immunoreactivity using anti-ERG monoclonal antibodies in sarcomas is influenced by clone selection.

2014

The aim of the present study was to explore ERG immunoreactivity in a series of sarcomas, GIST and malignant rhabdoid tumor (MRT), considering the not fully elucidated specificity and sensitivity of this antibody. Paraffin-embedded tissue microarrays from those tumors were stained with anti-ERG against the C-terminus [(EPR3864(2)] and N-terminus (Clone 9FY). EPR3864(2) was positive in almost all angiosarcomas, and MRT.GIST were positive in a large proportion of cases (38.4%), and more than half the synovial sarcomas (52.7%) revealed EPR3864(2) staining. Several chondrosarcomas, osteosarcomas, rhabdomyosarcoma and Ewing's sarcoma family of tumors (ESFT) presented EPR3864(2) expression in a l…

Pathologymedicine.medical_specialtyGastrointestinal Stromal TumorsClone (cell biology)BiologySensitivity and SpecificityPathology and Forensic MedicineFusion geneTranscriptional Regulator ERGmedicineHumansRhabdomyosarcomaRhabdoid TumorRetrospective StudiesTissue microarrayBrain NeoplasmsSarcomasEwing's sarcomaAntibodies MonoclonalEwing's sarcomaSarcomaCell Biologymedicine.diseaseImmunohistochemistrySynovial sarcomaKidney NeoplasmsERGTrans-ActivatorsImmunohistochemistrySarcomaPathology, research and practice
researchProduct

Pautas en el diagnóstico morfológico, inmunohistoquímico y genético de los tumores de células redondas y pequeñas con especial referencia al sarcoma …

2012

Resumen El objetivo del presente trabajo es realizar una revision y actualizacion donde se describe el espectro de hallazgos morfologicos inmunohistoquimicos (IHQ) y geneticos moleculares en los sarcomas de Ewing/PNET (Ewing/PNET) asi como su diagnostico diferencial con otros tumores de celulas redondas y pequenas (TCRP) de hueso y partes blandas. La expresion IHQ de CD99, Fli1, HNK-1 y CAV1, unido a las alteraciones geneticas que muestran estos tumores, apoyan el diagnostico definitivo de esta neoplasia. La expresion de marcadores epiteliales (CK, EMA y/o CEA) en un TCRP no excluye la posibilidad de un Ewing/PNET; sin embargo, la diferenciacion miogenica practicamente excluye la posibilida…

Pathology and Forensic MedicineRevista Española de Patología
researchProduct

Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma

2010

Notch can act as an oncogene or as a tumour suppressor and thus can either promote or inhibit tumour cell growth. To establish Notch status in Ewing's sarcoma family of tumours (ESFT), we investigated the Notch pathway by gene expression profiling meta-analysis or immunohistochemistry in samples obtained from 96 and 24 ESFT patients, respectively. We found that although Notch receptors were highly expressed, Notch did not appear to be active, as evidenced by the absence of Notch receptors in cell nuclei. In contrast, we show that Notch receptors known to be active in colon adenocarcinoma, hepatocarcinoma, and pancreatic carcinoma stain cell nuclei in these tumours. High expression of the No…

Pathologymedicine.medical_specialtyCellNotch signaling pathwayBone NeoplasmsSarcoma EwingBiologyPathology and Forensic MedicineBasic Helix-Loop-Helix Transcription FactorsTumor Cells CulturedmedicineHumansHES1HEY1Transcription factorCell ProliferationCell NucleusHomeodomain ProteinsRegulation of gene expressionReceptors NotchCell growthGene Expression ProfilingNeoplasm ProteinsGene Expression Regulation Neoplasticmedicine.anatomical_structureNeoplastic Stem CellsCancer researchTranscription Factor HES-1Cyclin-dependent kinase 8Signal TransductionThe Journal of Pathology
researchProduct

Molecular Diagnosis of Ewing Sarcoma Family of Tumors

2009

To compare the sensitivity and specificity of fluorescence in situ hybridization (FISH) with reverse transcription polymerase chain reaction (RT-PCR) in the diagnosis of Ewing sarcoma family of tumors (ESFTs) and other small round-cell tumors (SRCTs) in formalin-fixed paraffin-embedded tissue assembled in tissue microarrays (TMAs). The second objective is to confirm the value of molecular methods and immunohistochemical (IHC) assays, to perform a differential diagnosis between ESFTs and SRCTs with similar or overlapping morphology.A total of 560 cases were selected for the present study out the 806 cases collected from the PROgnosis and THerapeutic Targets in the Ewing's Family of TumorS pr…

Pathologymedicine.medical_specialtyBone NeoplasmsSarcoma EwingIn situ hybridizationBiologyTranslocation GeneticPathology and Forensic MedicinePredictive Value of TestsBiomarkers TumormedicineHumansMolecular diagnostic techniquesRNA NeoplasmParaffin embeddingMolecular BiologyIn Situ Hybridization FluorescenceParaffin Embeddingmedicine.diagnostic_testReverse Transcriptase Polymerase Chain ReactionDNA NeoplasmCell Biologymedicine.diseaseReverse transcription polymerase chain reactionReal-time polymerase chain reactionMolecular Diagnostic TechniquesTissue Array AnalysisFish <Actinopterygii>SarcomaFluorescence in situ hybridizationDiagnostic Molecular Pathology
researchProduct

Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors

2017

Ewing sarcoma is an aggressive neoplasm of pediatric and adolescent patients. Immunohistochemistry (IHC) can be used to support the morphologic diagnosis of Ewing sarcoma family of tumors (ESFT) in a convincing clinical/radiological context. Although neither NKX2.2 nor CD99 alone are entirely specific, when combined, the diagnostic specificity is high. The aim of the present study was to investigate the IHC expression of NKX2.2, ETV4 and BCOR in a large series of genetically confirmed ESFT. The results for CD99 and CAV-1 immunoreactivity, and the histological and fusion gene subtypes were retrieved from our previous study. NKX2.2 demonstrated moderate or strong nuclear positivity in 91.2% o…

0301 basic medicinePathologymedicine.medical_specialtyCD99Bone NeoplasmsContext (language use)Sarcoma EwingBiologyPathology and Forensic MedicineFusion gene03 medical and health sciences0302 clinical medicineProto-Oncogene ProteinsBiomarkers TumormedicineHumansNeoplasmHomeodomain ProteinsProto-Oncogene Proteins c-etsNuclear ProteinsCell BiologyZebrafish Proteinsmedicine.diseaseImmunohistochemistryRepressor ProteinsHomeobox Protein Nkx-2.2030104 developmental biology030220 oncology & carcinogenesisCancer researchbiology.proteinImmunohistochemistryAdenovirus E1A ProteinsSarcomaMorphologic diagnosisAntibodyTranscription FactorsPathology - Research and Practice
researchProduct

Tumor de células de la granulosa extraovárico con mutación FOXL2. Diagnóstico diferencial morfológico e inmunohistoquímico

2020

Extraovarian granulosa cell tumor is a very uncommon tumor and the identification of a recurrent mutation in FOXL2 may be used as another diagnostic tool along with the classical morphological and immunohistochemical findings. Here, we report a new case of extraovarian granulosa cell tumor in a 57 years old female patient presented with a sub-hepatic mass and abdominal pain. Histopathological examination of the excised mass showed features of adult-type granulosa cell tumor with α-inhibin, calretinin, WT1, S100, CD99 and progesterone receptor immunoreactivity. A FOXL2 mutation was detected on molecular biology study. A final diagnosis was an extraovarian adult-type granulosa cell tumor. We …

endocrine systemPathologymedicine.medical_specialtyAbdominal painurogenital systemGranulosa cellCD99BiologyPathology and Forensic Medicine03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisFemale patientProgesterone receptormedicineImmunohistochemistry030211 gastroenterology & hepatologyDifferential diagnosisCalretininmedicine.symptomRevista Española de Patología
researchProduct

mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts

2011

Abstract Background Conventional high-grade osteosarcoma is a primary malignant bone tumor, which is most prevalent in adolescence. Survival rates of osteosarcoma patients have not improved significantly in the last 25 years. Aiming to increase this survival rate, a variety of model systems are used to study osteosarcomagenesis and to test new therapeutic agents. Such model systems are typically generated from an osteosarcoma primary tumor, but undergo many changes due to culturing or interactions with a different host species, which may result in differences in gene expression between primary tumor cells, and tumor cells from the model system. We aimed to investigate whether gene expressio…

musculoskeletal diseaseslcsh:Internal medicinelcsh:QH426-470Transplantation HeterologousHeterologousBone NeoplasmsBiologyMiceCell Line TumorGene expressionDatabases GeneticGeneticsmedicineAnimalsHumansGenetics(clinical)RNA Messengerlcsh:RC31-1245Survival rateneoplasmsGenetics (clinical)Oligonucleotide Array Sequence AnalysisOsteosarcomaGene Expression Profilingmedicine.diseasePrimary tumorMolecular biologyTransplantationGene expression profilinglcsh:GeneticsCell cultureCancer researchOsteosarcomaResearch ArticleBMC Medical Genomics
researchProduct

Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, “undifferentiated small round cell tumors”. A…

2017

Abstract Background Despite extensive immunohistochemical (IHC) and molecular studies combined with morphologic findings, a group of round/ovoid cell tumors histologically similar to Ewing sarcomas (ES) but lacking EWSR1-rearrangements may remain unclassifiable. Design We retrospectively analyzed 41 Ewing-like tumors (formalin-fixed, paraffin-embedded) previously determined as negative or non-informative for EWSR1-rearrangements by FISH and/or RT-PCR. A new histopathology revision and additional IHC and molecular analyses were carried out in order to investigate whether additional IHC and/or molecular testing in combination with the morphological findings may help in reaching a definitive d…

AdultMale0301 basic medicinePathologymedicine.medical_specialtyAdolescentDesmoplastic small-round-cell tumorSarcoma EwingSclerosing rhabdomyosarcomaImmunophenotypingPathology and Forensic MedicineYoung Adult03 medical and health sciences0302 clinical medicineBiomarkers TumormedicineHumansStromal tumorChildAgedRetrospective StudiesHomeodomain ProteinsGiSTbusiness.industryNuclear ProteinsCell DifferentiationGeneral MedicineMiddle AgedPrognosismedicine.diseaseImmunohistochemistrySynovial sarcomaMolecular TypingHomeobox Protein Nkx-2.2030104 developmental biology030220 oncology & carcinogenesisSarcoma Small CellFemaleSarcomaClear-cell sarcomaRNA-Binding Protein EWSbusinessTranscription FactorsMyoepithelial TumorAnnals of Diagnostic Pathology
researchProduct

COX-2 expression in chondrosarcoma: A role for celecoxib treatment?

2010

Chondrosarcomas are resistant to conventional chemo- and radiotherapy. A subset of chondrosarcomas arises secondarily in the benign tumour syndromes enchondromatosis (EC) and multiple osteochondromas (MO), and prevention of tumour development would greatly improve prognosis. We therefore investigated the effect of selective COX-2 inhibition on chondrosarcoma growth. COX-2 expression was studied in central- and peripheral cartilaginous tumours. The effect of COX-2 inhibition was assessed in four high-grade chondrosarcoma cell lines using celecoxib and NS-398 treatment. COX-2 activity (prostaglandin E-2 (PGE(2)) ELISA) and cell viability were measured. The (prophylactic) effect of celecoxib o…

musculoskeletal diseasesMaleCancer ResearchPathologymedicine.medical_specialtyCell Survivalmedicine.medical_treatmentChondrosarcomaDrug Evaluation PreclinicalMice NudeAntineoplastic AgentsBone NeoplasmsMiceIn vivomedicineTumor Cells CulturedAnimalsHumansViability assaySulfonamidesCyclooxygenase 2 Inhibitorsbusiness.industryCartilagemedicine.diseaseXenograft Model Antitumor AssaysRadiation therapyDisease Models Animalmedicine.anatomical_structureOncologyBone tumours Chondrosarcoma COX-2 inhibition Therapy Xenograft familial adenomatous polyposis cell-line cyclooxygenase-2 inhibitor trial tumors establishment emphasis origin boneCell cultureCelecoxibCyclooxygenase 2CelecoxibPyrazolesChondrosarcomabusinessmedicine.drugProstaglandin E
researchProduct

Malignant Peripheral Nerve Sheath Tumor With Osseous Heterologous Differentiation in Uncommon Locations (Heart and Retropharynx)

2016

We report two cases of malignant peripheral nerve sheath tumor (MPNST) in an uncommon location (heart and retropharynx) both with divergent osseous heterologous differentiation. We present the pathological and immunohistochemical studies that confirmed the neurogenic origin. The histopathology of the tumor arising in the retropharynx showed a transition from a neurofibroma to MPNST, making this a new report of an MPNST arising from a plexiform neurofibroma without neurofibromatosis. Primary cardiac MPNST with osseous differentiation has never been reported before. In conclusion, the histology of MPNSTs is very heterogeneous, showing no specific diagnostic immunoprofile or genetic alteration…

AdultMalemedicine.medical_specialtyPathologySoft Tissue NeoplasmHeterologousSoft Tissue NeoplasmsMalignant peripheral nerve sheath tumor030204 cardiovascular system & hematologyBiologyPathology and Forensic MedicineHeart NeoplasmsYoung Adult03 medical and health sciences0302 clinical medicinePlexiform neurofibromaBiomarkers TumormedicineHumansNeurofibromamalignant peripheral nerve sheath tumorNeurofibromatosisNeurofibroma PlexiformOssification HeterotopicCell Differentiationmedicine.diseaseImmunohistochemistrydivergent heterologous differentiation030220 oncology & carcinogenesisPharynxImmunohistochemistryFemaleSurgeryHistopathologyheart and retropharynxAnatomyNeurilemmoma
researchProduct

Tissue microarrays analysis in chondrosarcomas: light microscopy, immunohistochemistry and xenograft study

2008

Abstract Background Chondrosarcoma (Chs) is the third most frequent primary malignant tumour of bone and can be primary or secondary, the latter results mainly from the malignant transformation of a benign pre-existing tumour. Methods All the cases diagnosed as Chs (primary tumours, recurrences and/or metastasis and xenotransplanted Chs) from the files of our Department were collected. Only cases with paraffin blocks available were selected (Total 32 cases). Six Tissue Microarrays (TMAs) were performed and all the cases and biopsies were distributed into the following groups: a) only paraffin block available from primary and/or metastatic tumours (3 TMAs), b) paraffin block available from p…

Pathologymedicine.medical_specialtyTissue microarrayHistologyintegumentary systembusiness.industryCD99General Medicinemedicine.diseaseMalignant transformationStainingMetastasisPathology and Forensic MedicineProceedingshemic and lymphatic diseasesSurvivinlcsh:PathologymedicineImmunohistochemistryChondrosarcomabusinessskin and connective tissue diseaseslcsh:RB1-214Diagnostic Pathology
researchProduct

Histologic transformation to diffuse large B cell lymphoma with profuse signet-ring cell change in bone marrow and lymph node biopsies in a patient w…

2016

0301 basic medicinePathologymedicine.medical_specialtyHistologySignet ring cellbusiness.industryGeneral Medicinemedicine.diseasePathology and Forensic Medicine03 medical and health sciencesTransformation (genetics)030104 developmental biology0302 clinical medicinemedicine.anatomical_structure030220 oncology & carcinogenesisCytologymedicineBone marrowDifferential diagnosisbusinessLymph nodeDiffuse large B-cell lymphomaHistological correlationDiagnostic Cytopathology
researchProduct

Functional characterization of osteosarcoma cell lines provides representative models to study the human disease

2011

Cancer cell lines represent in vitro models for studying malignancies, general cell biology, drug discovery and more. Whether they can be considered as exact representative models of the parental tumors remains uncertain given the acquisition of additional ex vivo changes of the cells and the lack of tissue architecture and stroma. Previously, within the EuroBoNeT consortium, we characterized a collection of bone sarcoma cell lines on genomic and proteomic level. Here, we address the phenotypical and functional characterization of the unique set of osteosarcoma cell lines (n=19) in vitro and in vivo. For functional analysis of differentiation capacity, cells were stimulated towards osteobla…

musculoskeletal diseasesPathologymedicine.medical_specialtyMice NudeBone NeoplasmsBiologymedicine.disease_causePathology and Forensic MedicineMiceHuman diseasecontaminationU2OSCell Line TumorMNNGmedicineoriginAnimalsHumansNeoplasm MetastasisneoplasmsMolecular BiologyOsteosarcomaGene Expression ProfilingHOSCell DifferentiationCell Biologymedicine.diseaseImmunohistochemistrytumorigenesisCell cultureCancer geneticsCancer researchOsteosarcomamisidentificationSarcoma ExperimentalSarcomaCarcinogenesisNeoplasm Transplantation
researchProduct

Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma

2021

Ewing sarcoma (EWS) is an aggressive bone and soft tissue tumor of children and young adults in which the principal driver is a fusion gene, EWSR1-FLI1. Although the essential role of EWSR1-FLI1 protein in the regulation of oncogenesis, survival, and tumor progression processes has been described in-depth, little is known about the regulation of chimeric fusion-gene expression. Here, we demonstrate that the active nuclear HDAC6 in EWS modulates the acetylation status of specificity protein 1 (SP1), consequently regulating the SP1/P300 activator complex binding to EWSR1 and EWSR1-FLI1 promoters. Selective inhibition of HDAC6 impairs binding of the activator complex SP1/P300, thereby inducing…

Cancer ResearchCarcinogenesisSarcoma EwingBiologymedicine.disease_causeHistone Deacetylase 6ArticleFusion genePaediatric cancerDownregulation and upregulationGeneticsmedicineHumansDoxorubicinPromoter Regions GeneticMolecular BiologyActivator (genetics)Proto-Oncogene Protein c-fli-1AcetylationOncogenesmedicine.diseaseTumor progressionFLI1Cancer researchSarcomaCarcinogenesismedicine.drug
researchProduct

Epithelioid Hemangioma (Angiolymphoid Hyperplasia With Eosinophilia) of the Heart With Peripheral Eosinophilia and Nephrotic Syndrome

2015

Epithelioid hemangioma (EH) is a rare benign vascular lesion, characterized by endothelial cells with epithelioid/histiocytoid appearance. Heart involvement is extremely rare. We present an unusual case of cardiac EH in a young woman with supraventricular arrhythmia, nephrotic syndrome (membranous glomerulopathy), and peripheral eosinophilia after a pregnancy and normal partum resembling Kimura disease. Echocardiogram showed a large tumor mass in the right cardiac ventricle. The cardiac tumor was removed and the histopathology revealed an endothelial proliferation associated with abundant eosinophils. The neoplastic endothelial cells were eosinophilic and polygonal with epithelioid/histioc…

AdultCD31medicine.medical_specialtyPathologyNephrotic SyndromeHeart Diseases030204 cardiovascular system & hematologyPathology and Forensic MedicineHemangioma03 medical and health sciences0302 clinical medicineEosinophilicmedicineHumansEosinophiliaAngiolymphoid hyperplasia with eosinophiliaEpithelioid Hemangiomabusiness.industryEndothelial CellsAngiolymphoid Hyperplasia with Eosinophiliamedicine.disease030220 oncology & carcinogenesisFemaleSurgeryKimura DiseaseHistopathologyAnatomymedicine.symptomHemangiomabusinessInternational Journal of Surgical Pathology
researchProduct

Abstract PR10: Inhibition of deacetylase SIRT1 offers a novel treatment option in metastatic Ewing sarcoma

2014

Abstract Metastasis is the major cause of disease-related death in Ewing sarcoma. Patients, who present with clinically overt disseminated disease at diagnosis and those who relapse early with distant metastases have a poor outcome despite multi-modal high-dose chemotherapy. Therefore, new treatment options are highly warranted. Ewing sarcoma pathogenesis is driven by the chimeric ETS oncogene EWS-FLI1. We here describe regulation of sirtuin SIRT1 by EWS-FLI1 and its role in metastasis. SIRT1 belongs to a family of NAD+-dependent group III deacetylases that target histone and non-histone proteins in response to metabolic stress resulting in widespread gene expression changes through epigene…

Cancer ResearchPathologymedicine.medical_specialtyOncogeneNotch signaling pathwayBiologymedicine.diseasePediatric cancerPrimary tumorMetastasisOncologyMetastatic Ewing SarcomaSirtuinCancer researchbiology.proteinmedicineSarcomaCancer Research
researchProduct

Histiocitosis de células de Langerhans de partes blandas y hueso con células gigantes multinucleadas y mutación BRAF V600E

2021

Resumen La histiocitosis de celulas de Langerhans (HCL) es una enfermedad heterogenea caracterizada por una proliferacion de celulas de Langerhans y la presencia de la mutacion BRAF en aproximadamente la mitad de los casos. La afectacion osea es comun pero la presencia de grandes masas en partes blandas no es habitual. Reportamos un caso de un paciente pediatrico que comenzo con una gran masa tumoral en hueso iliaco izquierdo con extension a partes blandas adyacentes. La tomografia axial computarizada mostraba una lesion osteolitica con gran extension a partes blandas. Se realizo una biopsia quirurgica por curetaje y el diagnostico histopatologico fue de HCL con positividad intensa para CD1…

030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisPathology and Forensic MedicineRevista Española de Patología
researchProduct

Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma…

2011

Summary Lysine-specific demethylase 1 (GeneID 23028), a flavin-dependent monoamine oxidoreductase and a histone demethylase, serves as an epigenetic coregulator of transcription. Lysine-specific demethylase 1 is up-regulated in neuroblastoma and in bladder, breast, colorectal, gastric, lung, and neuroendocrine cancers, and its overexpression drives the cell cycle of otherwise nontransformed human cells, suggesting oncogenic properties. Lysine-specific demethylase 1 was recently reported to be also overexpressed in several different mesenchymal tumors. We investigated lysine-specific demethylase 1 expression in over 500 sarcomas by gene expression profiling and tissue microarray-coupled immu…

ChondrosarcomaBone NeoplasmsSarcoma Ewingcomplex mixturesPathology and Forensic MedicineNeuroblastomaRhabdomyosarcomamedicineHumansRhabdomyosarcomaCell ProliferationHistone DemethylasesOsteosarcomabiologyGene Expression ProfilingEwing's sarcomaKDM1Amedicine.diseaseMolecular biologySynovial sarcomaCancer researchbiology.proteinbacteriaDemethylaseOsteosarcomaSarcomaTranylcypromineHuman Pathology
researchProduct

Evaluation of prognostic factors and their capacity to predict biological behavior in gastrointestinal stromal tumors.

2011

Gastrointestinal stromal tumors (GISTs) are c-KIT-signaling-driven mesenchymal tumors of the human digestive tract, many of which have c-KIT or PDGFRα activating mutations. The authors studied the immunohistochemical markers, c-KIT and PDGFRα mutations, in GISTs and their association with the clinicopathological and clinical follow-up in 145 GISTs. Tumors were located mainly in the stomach, the median tumor size being 7.5 cm. The mitotic index was ≤5 mitoses per 50 high-power fields in 61% of cases, 96% expressed CD117, and c-KIT or PDGFRα mutations were detected in 68% of cases. The median follow-up of the series was 52 months (range = 1 to 244.9 months). Tumor size, cell morphology, mito…

AdultMalePathologymedicine.medical_specialtyStromal cellMitotic indexReceptor Platelet-Derived Growth Factor alphaGastrointestinal Stromal Tumorsmedicine.disease_causeCell morphologyDisease-Free SurvivalPathology and Forensic MedicineYoung AdultPredictive Value of TestsStomach NeoplasmsIntestinal NeoplasmsmedicineBiomarkers TumorMitotic IndexHumansAgedAged 80 and overMutationbiologyCD117StomachMesenchymal stem cellMiddle AgedPrognosisProto-Oncogene Proteins c-kitmedicine.anatomical_structureKi-67 AntigenMutationbiology.proteinImmunohistochemistrySurgeryFemaleAnatomyInternational journal of surgical pathology
researchProduct

Solitary Fibrous Tumor of the Vulva: Report of 2 Cases, Including a De Novo Dedifferentiated Solitary Fibrous Tumor Diagnosed After Molecular Demonst…

2018

Solitary fibrous tumor (SFT) is a neoplasm of fibroblastic lineage that has been documented in almost every anatomic location. Vulval SFT is very rare with only 10 cases reported to date. We present 2 additional SFTs located in the vulva, in adult women of 59 and 25 yr of age. The first showed a classic morphology and immunophenotype with uniform and strong STAT6 nuclear expression. The other one was a spindle-cell de novo dedifferentiated SFT with heterogeneous nuclear and cytoplasmic STAT6 staining, which could only be correctly diagnosed after molecular analysis with demonstration of a NAB2-STAT6 gene fusion. This genetic aberration is considered to represent the major pathogenic driver …

0301 basic medicineAdultPathologymedicine.medical_specialtySolitary fibrous tumorLineage (genetic)Oncogene Proteins FusionBiologyPathology and Forensic MedicineVulvaVulva03 medical and health sciences0302 clinical medicineImmunophenotypingmedicineNeoplasmHumansOncogene FusionDedifferentiated Solitary Fibrous TumorVulvar NeoplasmsObstetrics and GynecologyMiddle Agedmedicine.diseaseRepressor Proteins030104 developmental biologymedicine.anatomical_structure030220 oncology & carcinogenesisSolitary Fibrous TumorsOncogene FusionFemaleDifferential diagnosisSTAT6 Transcription FactorInternational journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
researchProduct

Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A…

2016

Abstract Background Differentiation of Ewing sarcoma family of tumors (ESFT) and Ewing-like tumors remains problematic. Certain ESFT with morphological and immunohistochemical (IHC) profiles lack the EWSR1-ETS transcript. To improve diagnostic accuracy we investigated the presence of several specific transcripts in 200 small round cell tumors (SRCT) displaying ESFT morphology and immunophenotype in which EWSR1 FISH analysis was non-informative or negative. Design 200 tumors (formalin-fixed, paraffin-embedded) were analyzed by RT-PCR. All tumors were tested for EWSR1-ETS , EWSR1 / WT1 , PAX3 / 7-FOX01 or SYT / SSX transcripts, and the negative tumors were subsequently analyzed for CIC / DUX4…

0301 basic medicinePathologymedicine.medical_specialtyOncogene Proteins FusionDesmoplastic small-round-cell tumorCD99Sarcoma EwingBiologyTranslocation GeneticPathology and Forensic MedicineDiagnosis DifferentialFusion gene03 medical and health sciences0302 clinical medicineImmunophenotypingBiomarkers TumormedicineHumansPathology MolecularIn Situ Hybridization FluorescenceRNA-Binding ProteinsGeneral Medicinemedicine.diseaseSynovial sarcoma030104 developmental biology030220 oncology & carcinogenesisSarcoma Small CellImmunohistochemistryCalmodulin-Binding ProteinsSarcomaRNA-Binding Protein EWSDifferential diagnosisAnnals of Diagnostic Pathology
researchProduct

Neuroendocrine differentiation in a large series of genetically-confirmed Ewing’s sarcoma family tumor: Does it provide any diagnostic or prognostic …

2021

Given the potential for neuroendocrine differentiation in Ewing's sarcoma family of tumors (ESFT), we aimed to determine neuroendocrine expression in a large series of genetically-confirmed ESFT and its prognostic significance in clinically-localised neoplasms (n = 176). Slides prepared from tissue microarrays were stained for Insulinoma-associated protein 1 (INSM1), CD56, chromogranin-A and synaptophysin. INSM1 expression was present in 59% of ESFT, while synaptophysin, chromogranin-A and CD56 were expressed in only 13%, 8% and 5% of ESFT, respectively. Histological subtypes were only significantly correlated with INSM1 (p = 0.032) or CD56 (p = 0.016) immunoexpression. Regarding prognosis,…

0301 basic medicinePrognostic factorLung NeoplasmsSynaptophysinSarcoma EwingNeuroendocrine differentiationPathology and Forensic Medicine03 medical and health sciences0302 clinical medicineBiomarkers TumormedicineHumansTissue microarraybiologybusiness.industryEwing's sarcomaLarge seriesChromogranin ACell DifferentiationCell Biologymedicine.diseaseCarcinoma NeuroendocrineRepressor Proteins030104 developmental biology030220 oncology & carcinogenesisSynaptophysinbiology.proteinCancer researchSarcomabusinessPathology - Research and Practice
researchProduct

Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.

2010

Our limited understanding of the biological impact of the whole spectrum of early breast lesions together with a lack of accurate molecular-based risk criteria for the diagnosis and assignment of prognostic significance to biopsy findings presents an important problem in the clinical management of patients harboring precancerous breast lesions. As a result, there is a need to identify biomarkers that can better determine the outcome of early breast lesions by identifying subpopulations of cells in breast premalignant disease that are at high-risk of progression to invasive disease. A first step towards achieving this goal will be to define the molecular phenotypes of the various cell types …

ProteomicsPaperCancer ResearchCell typeMammary glandProtein Array AnalysisMuscle ProteinsBreast NeoplasmsBiologyBioinformaticsProteomicsMass SpectrometryImmunophenotypingCytokeratinImmunophenotypingGeneticsmedicineHumansProtein IsoformsElectrophoresis Gel Two-DimensionalBiomarker discoveryDatabases ProteinMammary Glands HumanKeratin-19Proteomic ProfilingKeratin-15Epithelial CellsGeneral MedicineImmunohistochemistrymedicine.anatomical_structurePhenotypeOncologyMolecular MedicineFemaleStem cellBiomarkersMolecular oncology
researchProduct

Extra-Adrenal Adult Neuroblastoma With Aberrant Germ Cell Marker Expression: Maturation After Chemotherapy as an Important Clue to a Challenging Diag…

2019

Adult neuroblastoma is an extremely infrequent neoplasm, usually occurring in the adrenal medulla or in the paraspinal sympathetic ganglia, as its childhood counterpart. We report a very unusual case of a Schwannian stroma-poor adult neuroblastoma of inguinal location, showing aberrant expression of germ cell markers: SALL4 and OCT4. This aberrant marker expression, the unusual positivity for NKX2.2 and the very scattered (instead of diffuse strong) PHOX2B expression, complicated the initial diagnosis. In this case, the posttreatment histological evaluation revealed the neuroblastic nature of the lesion. Neuroblastoma maturation after treatment is an unusual finding in adults, and in this …

AdultMalePathologymedicine.medical_specialtymedicine.medical_treatmentInguinal CanalBiologyPathology and Forensic MedicineDiagnosis DifferentialLesionNeuroblastomaSALL4NeuroblastomaAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumormedicineHumansIfosfamideCyclophosphamideEtoposideHomeodomain ProteinsChemotherapyExtra-AdrenalNuclear ProteinsChemoradiotherapymedicine.diseaseGerm CellsHomeobox Protein Nkx-2.2medicine.anatomical_structureVincristineAbdominal NeoplasmsDactinomycinSurgeryAnatomymedicine.symptomAdrenal medullaOctamer Transcription Factor-3Germ cellAfter treatmentTranscription FactorsInternational Journal of Surgical Pathology
researchProduct

High-risk gastrointestinal stromal tumour (GIST) and synovial sarcoma display similar angiogenic profiles: a nude mice xenograft study

2016

Background: Gastrointestinal stromal tumour (GIST) is the most common primary mesenchymal tumour of the gastrointestinal tract. Spindle cell monophasic synovial sarcoma (SS) can be morphologically similar. Angiogenesis is a major factor for tumour growth and metastasis. Our aim was to compare the angiogenic expression profiles of high-risk GIST and spindle cell monophasic SS by histological, immunohistochemical and molecular characterisation of the neovascularisation established between xenotransplanted tumours and the host during the initial phases of growth in nude mice. Methods: The angiogenic profile of two xenotransplanted human soft-tissue tumours were evaluated in 15 passages in nude…

0301 basic medicineCancer ResearchPathologymedicine.medical_specialtynude mice xenograftStromal cellAngiogenesischemokinessynovial sarcomaMetastasisangiogenesis03 medical and health sciences0302 clinical medicineMonophasic Synovial SarcomaMedicineGiSTbusiness.industryResearchMesenchymal stem cellmedicine.diseaseSynovial sarcoma030104 developmental biologyOncology030220 oncology & carcinogenesisImmunohistochemistrybusinessGISTecancermedicalscience
researchProduct

A tissue microarray study of osteosarcoma: histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models.

2010

Osteosarcomas (OS) are aggressive neoplasms with a wide range of morphologic patterns.OS cases (primary and xenotransplanted) with paraffin blocks available were collected and included in tissue microarrays (TMAs). A morphologic evaluation including the different passages in mice was carried out according to the new WHO criteria. In addition, TMAs were analyzed with a wide panel of immunohistochemical (IHC) markers (osteonectin, osteocalcin,cytokeratin, S100, Sox-9, Ki-67, Bcl-2, p53, p16, survivin, CD99, and caveolin-1).A total of 61 cases were collected. The distribution of the cases according to the histopathologic pattern was: 38 osteogenic OS, 8 primary chondrogenic OS, 2 primary telan…

MalePathologymedicine.medical_specialtyHistologyCD99OsteocalcinTransplantation HeterologousMice NudePathology and Forensic MedicineCytokeratinMiceSurvivinmedicineBiomarkers TumorAnimalsHumansOsteonectinOsteosarcomaTissue microarraybiologybusiness.industrymedicine.diseaseMicroarray AnalysisImmunohistochemistryTransplantationMedical Laboratory TechnologyDisease Models Animalbiology.proteinCancer researchDisease ProgressionImmunohistochemistryOsteosarcomaFeasibility StudiesOsteonectinbusinessApplied immunohistochemistrymolecular morphology : AIMM
researchProduct

The Role of Immunohistochemistry in Rhabdomyosarcoma Diagnosis Using Tissue Microarray Technology and a Xenograft Model

2015

Rhabdomyosarcomas (RMS) may resemble other non-myogenic sarcomas and malignant rhabdoid tumor (MRT). Alveolar rhabdomyosarcoma (ARMS) often harbors a typical translocation, but embryonal rhabdomyosarcoma (ERMS) lacks any specific rearrangement. Histopathology is not always sufficient for an unequivocal diagnosis, necessitating ancillary studies, including immunohistochemistry (IHC). Sixteen genetically tested RMS and two MRT were xenografted and followed in successive passages. Tissue microarrays were constructed including samples from original and xenograft tumors. Desmin, myogenin, CK, EMA, INI1, LSD1, AP2 beta, fibrillin-2, HMGA2, nestin, and SIRT1 were tested using immunohistochemical s…

Malemusculoskeletal diseasesmedicine.medical_specialtyPathologygenetic structuresMice NudeBiologyPathology and Forensic MedicineDiagnosis DifferentialMiceRhabdomyosarcomaBiomarkers TumormedicineAnimalsHumansRhabdomyosarcomaRhabdoid TumorTissue microarraytissue microarraysGeneral MedicineNestinmedicine.diseasemusculoskeletal systemImmunohistochemistryDisease Models AnimalxenograftsTissue Array AnalysisPediatrics Perinatology and Child HealthimmunohistochemistryAlveolar rhabdomyosarcomaCancer researchHeterograftsImmunohistochemistryHistopathologyDesminEmbryonal rhabdomyosarcomarhabdomyosarcoma
researchProduct

Unusual Neuroendocrine Differentiation in a Small Round Cell Angiosarcoma: A Potential Histologic Mimicker of Superficial Ewing Sarcoma.

2018

Neuroendocrine differentiation or aberrant expression of neuroendocrine markers is very uncommon in angiosarcomas (AS) and creates a challenging differential diagnosis with other superficial or soft tissue tumors. Herein, we report a new case of superficial AS presenting as a tumor lesion on the little finger of the right hand of a 52-year-old man. The tumor displayed CD56, chromogranin-A, and synaptophysin immunoreactivity. Tumor cells were positive for vascular markers (CD31, FLI1, ERG, D2-40, VE-cadherin, VEGR1,2, and 3), CD99, and EMA, but were negative for S100, CK (AE1/AE3), CK20, polyomavirus, and myogenic (desmin and myogenin) and melanocyte markers (melan-A and HMB45). Ki67 immunos…

CD31MalePathologymedicine.medical_specialtySkin NeoplasmsBiopsyCD99HemangiosarcomaDermatologySarcoma EwingNeuroendocrine differentiationPathology and Forensic MedicineDiagnosis DifferentialFingers030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinePredictive Value of TestsBiopsymedicineBiomarkers TumorHumansAngiosarcomaIn Situ Hybridization FluorescenceCell Proliferationbiologymedicine.diagnostic_testMerkel cell carcinomabusiness.industryCell DifferentiationGeneral MedicineMiddle Agedmedicine.diseaseImmunohistochemistryCarcinoma Neuroendocrine030220 oncology & carcinogenesisSarcoma Small CellSynaptophysinbiology.proteinSarcomabusinessThe American Journal of dermatopathology
researchProduct

Ki-67 immunoexpression and radiological assessment of necrosis improves accuracy of conventional and modified core biopsy systems in predicting the f…

2021

Based on the French Federation Nationale des Centers de Lutte Contre le Cancer (FNCLCC) grading system, this study assesses the accuracy of conventional and modified core biopsy (CB) systems in predicting the final grade (low vs high) assigned to the resected specimen. Substituting Ki-67 immunoexpression for mitotic count, and radiological for histological assessment of necrosis, we used two modified FNCLCC CB grading systems: (1) Ki-67 immunoexpression alone, and (2) Ki-67 plus radiological assessment of necrosis. We graded 199 soft tissue sarcomas (STS) from nine centers, and compared the results for the conventional (obtained from local histopathology reports) and modified CB systems wit…

AdultMalemedicine.medical_specialtySoft Tissue NeoplasmsPathology and Forensic MedicineRadiological necrosisNecrosisCore biopsymedicineBiomarkers TumorHumansGrading (education)Retrospective StudiesNot evaluatedReceiver operating characteristicbiologybusiness.industrySarcomasSoft tissueSarcomaCell Biologymedicine.diseaseKi-67 AntigenRadiological weaponKi-67biology.proteinKi-67HistopathologyFemaleSarcomaBiopsy Large-Core NeedleNuclear medicinebusinessFNCLCC grading system
researchProduct

Ewing-like sarcoma with CIC-DUX4 gene fusion in a patient with neurofibromatosis type 1. A hitherto unreported association.

2015

Sarcoma with CIC-DUX4 gene fusion is emerging as the most prevalent subset of Ewing-like undifferentiated small round cell sarcomas with around 50 cases published. We report hereby the case of a 40-year-old male who presented a CIC-DUX4 sarcoma in deep soft tissues in his thigh. He had been diagnosed with neurofibromatosis type 1 at age 19 and over the years underwent resection of multiple neural neoplasms, including two malignant peripheral nerve sheath tumors with classical spindle-cell histopathology. The CIC-DUX4 sarcoma was treated with surgical resection, radiation and chemotherapy, but lung and brain metastases developed and the patient died from the disease 14 months after diagnosis…

AdultMalePathologymedicine.medical_specialtySoft Tissue NeoplasmLung NeoplasmsNeurofibromatosis 1Oncogene Proteins Fusionmedicine.medical_treatmentSoft Tissue NeoplasmsThighBiologyPathology and Forensic MedicineFusion geneFatal OutcomemedicineHumansNeurofibromatosisChemotherapyBrain NeoplasmsSoft tissueCell Biologymedicine.diseasemedicine.anatomical_structureSarcoma Small CellHistopathologySarcomaPathology, research and practice
researchProduct

Desmoplastic melanoma may mimic a cutaneous peripheral nerve sheath tumor: Report of 3 challenging cases

2017

Desmoplastic melanoma (DM) and cutaneous malignant peripheral nerve sheath tumors (MPNST) reveal histological and immunohistochemical similarities, including S100 positivity and negative staining for conventional melanocytic markers. We present 3 cases of cutaneous S100-positive spindle cell tumors in elderly patients, in which first findings led to initial misdiagnoses as cutaneous MPNST and benign peripheral sheath nerve tumor (neurofibroma). The identification of adjacent atypical melanocytic hyperplasia in the overlying skin along with tumor cell proliferation, also in the superficial dermis, the neurotropic component and the absence of any relationship between the tumor and a major ner…

Desmoplastic melanomaPathologymedicine.medical_specialtyHistologyintegumentary systembusiness.industryMelanomaDermatologymedicine.diseasePathology and Forensic MedicineBenign tumor030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureDermis030220 oncology & carcinogenesismedicineNeurofibromaImmunohistochemistryNeurofibromatosisbusinessPeripheral Nerve SheathJournal of Cutaneous Pathology
researchProduct

Tumor de Wilms con diferenciación muscular. Histología, inmunofenotipo y análisis molecular de tres casos

2012

Resumen El nefroblastoma o tumor de Wilms (WT) es una neoplasia de origen embrionario de histologia trifasica que simula estadios diferentes de la nefrogenesis, y esta constituido tanto por celulas blastemales indiferenciadas como por celulas epiteliales y estromales bien diferenciadas. El predominio de uno de sus componentes en mas de dos terceras partes permite clasificar al WT en blastemal, epitelial, estromal o mixto cuando no hay predominio de uno de ellos. Los tumores con predominio de elementos estromales con un 30% o mas de diferenciacion muscular se reconocen como de variante rabdomioblastica o con diferenciacion muscular. El presente trabajo comunica los hallazgos histologicos, in…

Pathology and Forensic MedicineRevista Española de Patología
researchProduct

Immunohistochemical Study as a Tool in Differential Diagnosis of Pediatric Malignant Rhabdoid Tumor

2010

Malignant rhabdoid tumors (MRTs) are aggressive childhood neoplasms, occurring mainly in the kidney and brain. We describe 2 unusual cases of extrarenal and noncranial location (liver and soft tissue with dissemination) mimicking hepatoblastoma, neuroblastoma or Ewing sarcoma. Both cases revealed a polyphenotypic profile, combined with cytokeratin, vimentin, and CD99 expression. INI1/BAF-47 showed negative protein nuclear expression in both cases, suggesting a diagnosis of MRT. An extensive immunohistochemical panel was performed to exclude pediatric tumors reminiscent of MRT. The genetic studies failed to detected MYCN amplification, 11q23 deletion, and EWS break-apart positivity. No alter…

HepatoblastomaPathologymedicine.medical_specialtySkin NeoplasmsHistologyDesmoplastic small-round-cell tumorChromosomal Proteins Non-HistoneCD9912E7 AntigenN-Myc Proto-Oncogene ProteinPathology and Forensic MedicineDiagnosis DifferentialNeoplasms Multiple PrimaryFatal OutcomeAntigens CDNeuroblastomaAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansVimentinRhabdoid TumorChromosome AberrationsOncogene ProteinsN-Myc Proto-Oncogene Proteinbusiness.industryLiver NeoplasmsInfant NewbornInfantNuclear ProteinsWilms' tumorSMARCB1 Proteinmedicine.diseaseImmunohistochemistryDNA-Binding ProteinsMedical Laboratory TechnologyDrug Resistance NeoplasmKeratinsFemaleSarcomaRNA-Binding Protein EWSDifferential diagnosisbusinessCell Adhesion MoleculesTranscription FactorsApplied Immunohistochemistry &amp; Molecular Morphology
researchProduct

Hyaline globules and papillary fragments in cytologic smears from two intra-abdominal tumors (ovarian and hepatic) in female patients: A diagnostic p…

2016

Hyaline globules and papillary fragments in cytologic samples from two intra-abdominal tumors in young females are presented including the cytological features and the correlation with the histopathologic and immunohistochemical findings. In the first case a cytologic study from an ovarian mass showed papillary structures and isolated tumor cells with epithelioid morphology, irregular reniform-like nuclear contour, pale or vacuolated cytoplasm, abundant hyaline globules and occasional glomeruloid structures resembling Schiller-Duval bodies. Yolk sac tumor (YST) was the diagnosis on the histological slides. Tumor cells showed positivity for cytokeratin (AE1/AE3), epithelial membrane antigen …

Pathologymedicine.medical_specialtyHistologybusiness.industryHistologyGeneral MedicineAnatomymedicine.diseasePathology and Forensic MedicineMetastatic carcinomaMetastasis03 medical and health sciencesCytokeratinIsolated Tumor Cells0302 clinical medicine030220 oncology & carcinogenesisClear cell carcinomaMedicine030211 gastroenterology & hepatologyGerm cell tumorsbusinessHyalineDiagnostic Cytopathology
researchProduct

Soft tissue myoepithelial carcinoma with rhabdoid-like features andEWSR1rearrangement: Fine needle aspiration cytology with histologic correlation

2015

A new case of soft tissue myoepithelial carcinoma (MEC) with rhabdoid-like differentiation is presented including cytologic, histopathologic, immunohistochemical, and molecular biologic features. A 45-year-old woman was admitted to the Hospital with nodular mass involving the lower part of the abdominal wall. Fine-needle aspiration cytology showed a round cell tumor with abundant cytoplasm in the myxoid background. The nuclei were uniform, round to ovoid, with finely distributed chromatin, nucleoli, and pale, vacuolated, or eosinophilic cytoplasm with rhabdoid-like appearance resembling a soft tissue malignant rhabdoid tumor. The surgically removed tumor was poorly demarcated, yellow, soft,…

medicine.medical_specialtyPathologyHistologybiologymedicine.diagnostic_testEpithelioid sarcomaCD99Soft tissueVimentinGeneral MedicineExtraskeletal Myxoid Chondrosarcomamedicine.diseasePathology and Forensic MedicineMalignant Myoepitheliomabiology.proteinmedicineHistopathologyFluorescence in situ hybridizationDiagnostic Cytopathology
researchProduct

The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing s…

2016

SATB2 is commonly expressed in osteosarcomas. Although apparently being a valuable diagnostic marker for differentiating between small cell osteosarcoma (SCO) and other small round cell tumors of bone, for instance Ewing sarcoma family of tumors (ESFT), it has not been tested in a large series of ESFT and chondrosarcomas so far. We studied the immunohistochemical expression of SATB2 in 42 osteosarcomas, 31 chondrosarcomas, and 371 genetically confirmed ESFT. SATB2 positivity was detected in 90.4% of osteosarcomas, 87.5% of SCO, 91.3% of osteoblastic osteosarcomas, and in all chondroblastic and parosteal osteosarcomas. The osteoblastic and SCO subtypes expressed SATB2 more intensely than oth…

musculoskeletal diseases0301 basic medicinePathologymedicine.medical_specialtyCD99ChondrosarcomaBone NeoplasmsSarcoma EwingSensitivity and SpecificitySmall Cell OsteosarcomaPathology and Forensic MedicineDiagnosis Differential03 medical and health sciences0302 clinical medicineChondroblastic OsteosarcomaBiomarkers TumormedicineHumansRetrospective StudiesOsteosarcomabusiness.industryOsteoidMatrix Attachment Region Binding ProteinsCell Biologymusculoskeletal systemmedicine.diseaseImmunohistochemistry030104 developmental biology030220 oncology & carcinogenesisImmunohistochemistryOsteosarcomaSarcomaChondrosarcomabusinessTranscription FactorsPathology - Research and Practice
researchProduct

Solitary Fibrous Tumor: Integration of Clinical, Morphologic, Immunohistochemical and Molecular Findings in Risk Stratification and Classification Ma…

2021

Although solitary fibrous tumors (SFTs) have an unpredictable evolution, some specific clinicopathologic factors have been associated with the final outcome. We retrieved clinical, pathological and molecular data of 97 patients with a histological diagnosis of SFT and Signal transducer and activator of transcription 6 (STAT6) positivity. We retrospectively studied the pathological factors predictive of recurrence/metastasis and compared them with the clinical outcome. A wide immunohistochemical study and molecular analysis to detect NAB2/STAT6 gene fusion, tumor protein-53 (TP53) and/or (telomerase reverse transcriptase) TERT promotor mutation were performed. The risk of metastasis was calc…

MalePathologymedicine.medical_specialtySolitary fibrous tumorQH301-705.5CD99CD34APAF-1Risk AssessmentArticleCatalysisMetastasisInorganic ChemistryBiomarkers TumormedicineHumanssolitary fibrous tumorTelomerase reverse transcriptaseBiology (General)risk stratification systemsPhysical and Theoretical ChemistryQD1-999Molecular BiologyPathological<i>p53</i> mutationSpectroscopyRetrospective StudiesSTAT6<i>HTER</i> mutationbusiness.industryOrganic ChemistrySoft tissueGeneral MedicineMiddle AgedPrognosismedicine.diseaseCombined Modality TherapyImmunohistochemistryp53 mutationComputer Science ApplicationsChemistryHTER mutationSolitary Fibrous TumorsImmunohistochemistryFemaleNeoplasm Recurrence LocalbusinessFollow-Up StudiesInternational Journal of Molecular Sciences
researchProduct

Models of Biobanking and Tissue Preservation: RNA Quality in Archival Samples in Pathology Laboratories and “In Vivo Biobanking” by Tumor Xenografts …

2011

Tissue banks represent essential resources and platforms for biomedical research serving basic, translational, and clinical research projects. In this article, we describe 2 models of biobanking and tissue preservation with different approaches and aims. Archive tissue biobanking is described here as a resource of residual pathology tissues for translational research, which represents the huge clinical heterogeneity. In this context, managing of tissues and RNA quality in archive tissue are discussed. The other model of tissue biobanking is referred to as xenograft tissue banking, which represents an alternative method for obtaining large amounts of tissue, over an indefinite period, in so …

Pathologymedicine.medical_specialtyTissue PreservationMedicine (miscellaneous)RNAContext (language use)Translational researchCell BiologyGeneral MedicineBiologymedicine.diseaseBiobankGeneral Biochemistry Genetics and Molecular BiologybiobankingxenograftsIn vivoArchive Tissues; RNA; biobanking; xenografts; TMA (tissue microarrays)Tissue bankmedicineArchive TissuesArchive TissueRNASarcomaxenograftTMA (tissue microarrays)
researchProduct